Q2 2025 National Research Corp Earnings Call Transcript
Key Points
- National Research Corp (NRC) reported a 2% sequential increase in Total Recurring Contract Value (TRCV), marking the third consecutive quarter of growth and the highest rate since early 2021.
- The company experienced the strongest year-to-date sales since 2021, with an increase in both win rate percentage and average win size.
- NRC added new customers to its base, highlighting the depth and integration of its capabilities and the human-centered nature of its customer service model.
- Adjusted EBITDA margin remained strong at 30%, reflecting disciplined cost management and operational efficiency.
- The company is well-positioned financially with modest leverage, positive cash flow generation, and healthy access to capital, enabling it to fund organic growth, M&A, and return cash to shareholders.
- The company is still in the process of searching for a new Chief Financial Officer, which could impact financial leadership and strategy execution.
- Despite positive momentum, the competitive environment remains challenging, with budget pressures on health system partners.
- The transition to new leadership under CEO Trent Green is still in its early stages, which may lead to uncertainties in strategic direction.
- There is no specific timeline or detailed plan for material investments or strategic initiatives, as the new CEO is still formulating a strategic plan.
- The healthcare industry is complex and deeply human, posing unique challenges that require specialized understanding and adaptation.
Hello, everyone, and welcome to today's NRC Health second-quarter 2025 earnings call. My name is Seb, and I'll be the operator for your call today.
I'll now hand you over to Jordan Freeman, Vice President of Finance. Please go ahead.
Thank you for joining NRC Health Q2 2025 earnings call. In this call, the company will make forward-looking statements. Such statements may be identified by the use of terms or phrases such as belief, expect, focus, potential, will, derivations thereof in similar terms and phrases.
Forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to risk and uncertainties. And some of which cannot be predicted or quantified, which could cause future events and actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statement, including those risks and uncertainties as set forth in the risk factor section of our annual report on Form 10-K
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
